RECRUITING

Quality of Life Assessment of Radiotherapy in Recurrent Head and Neck Cancer

Description

The purpose of this study is to examine the uses of a mobile health-based assessment and symptom monitoring platform.

Study Overview

Study Details

Study overview

The purpose of this study is to examine the uses of a mobile health-based assessment and symptom monitoring platform.

Quality of Life Assessment of Hypofractionated Radiotherapy in Recurrent Head and Neck Cancer: CPC-CT Pilot

Quality of Life Assessment of Radiotherapy in Recurrent Head and Neck Cancer

Condition
Head and Neck Cancer
Intervention / Treatment

-

Contacts and Locations

Oklahoma City

Stephenson Cancer Center, Oklahoma City, Oklahoma, United States, 73104

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age 18 years and older
  • * Written informed consent and any locally-required authorization obtained from the patients prior to performing any protocol-related procedures, including screening evaluations
  • * Pathologically (histologically or cytologically) proven diagnosis of cancer of the head and neck (nasopharynx, oral cavity, oropharynx, hypopharynx, larynx, or unknown primary)
  • * Locally recurrent or metastatic HNC not deemed amenable to curative-intent salvage therapy, in whom at least six months have passed since their prior RT, if received
  • * Must have evaluable lesion per RECIST v1.1
  • * Patients agree to provide their smoking history prior to registration
  • * ECOG performance status of 0-2
  • * Prior radiotherapy to the region of the study cancer within less than 6 months
  • * Patients who have received prior radiation therapy and who, in the opinion of the treating radiation oncologist, cannot be reirradiated safely without excess risk of severe toxicity given prior radiation dose to critical structures.
  • * Patients with known contraindications to radiotherapy, including inherited syndromes associated with hypersensitivity to ionizing radiation (e.g., Ataxia-Telangiectasia, Nijmegen Breakage Syndrome)
  • * Female patients who are pregnant

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Oklahoma,

Study Record Dates

2026-08-30